Effects of monensin on insulin processing in adipocytes. Evidence that the internalized insulin-receptor complex has
Abstract:
In the presence of 10-100 microM monensin (a monovalent cation ionophore), a considerable amount of 125I activity of iodoinsulin accumulated in isolated rat epididymal adipocytes during a 30-min incubation. The accumulation was secondary to the action of monensin to inhibit dissociation of a certain fraction of the cellbound 125I activity. This monensin effect was reversible. The accumulation of 125I activity was ATP dependent and so was the discharge of the accumulated radioactivity. Approximately 91% of the accumulated radio-activity was precipitable with trichloroacetic acid, and at least 84% was reactive to anti-insulin antibody. Monensin at 100 microM appeared to have only mild effects on the cellular activities of glucose transport and cAMP phosphodiesterase. Nevertheless, when cells were first exposed to 10 nM insulin in the presence of 100 microM monensin and then transferred into a hormone-free buffer that contained monensin, the phosphodiesterase activity in cells remained partially activated as if cells were kept exposed to approximately 0.5 nM insulin. Under similar conditions, glucose transport activity remained partially activated as if cells were incubated with approximately 70 pM insulin. Monensin did not inhibit the reversal of the insulin effect per se. Like monensin, 20-100 microM chloroquine (a lysosomotropic inhibitor) induced a considerable accumulation of [125I] iodoinsulin. However, cells that had been exposed to insulin in the presence of chloroquine retained little hormonal effect after washing. Based on these observations and on the reported biological effects of monensin, it is suggested (a) that monensin may induce intracellular accumulation of the insulin-receptor complex by blocking the acidification of endocytic vesicles and (b) that the accumulated insulin-receptor complex may retain a weak, but significant, capacity to stimulate both glucose transport and phosphodiesterase activities.
Insights
Monensin, an ionophore, causes insulin accumulation in rat fat cells by preventing its release. This accumulation is ATP-dependent and retains partial insulin signaling capacity for glucose transport and phosphodiesterase activity.
Area of Science:
- Biochemistry
- Cell Biology
- Endocrinology
Background:
- Insulin signaling is crucial for glucose metabolism.
- Endocytosis and intracellular trafficking regulate insulin receptor activity.
- Ionophores like monensin can disrupt cellular processes.
Purpose of the Study:
- To investigate the effect of monensin on insulin accumulation in isolated rat adipocytes.
- To determine the mechanism behind monensin-induced insulin accumulation.
- To assess the functional consequences of accumulated insulin-receptor complexes.
Main Methods:
- Incubation of isolated rat epididymal adipocytes with radiolabeled iodoinsulin and monensin.
- Measurement of accumulated radioactivity and its characteristics (e.g., TCA precipitation, antibody reactivity).
- Assessment of cellular glucose transport and cAMP phosphodiesterase activities under various conditions.
Main Results:
- Monensin (10-100 microM) significantly increased intracellular accumulation of iodoinsulin.
- Accumulation was ATP-dependent and inhibited insulin dissociation from cells.
- Accumulated complexes retained partial stimulatory capacity for glucose transport and phosphodiesterase.
- Chloroquine also induced insulin accumulation but resulted in loss of hormonal effect.
Conclusions:
- Monensin likely promotes intracellular insulin-receptor complex accumulation by inhibiting endocytic vesicle acidification.
- The accumulated complexes retain a functional capacity to stimulate key insulin-responsive pathways.
- These findings offer insights into the regulation of insulin signaling and receptor trafficking.
More Related Videos
Related Concept Videos
Insulin Secretory Vesicles
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are co-secreted in...
Insulin: The Receptor and Signaling Pathways
Insulin: Biosynthesis, Chemistry, and Preparation
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...


